QID 590583

Date Published: 2021-12-23

QID 590583: Emerson Ovation OCR400 Controller Multiple Vulnerabilities (ICSA-19-148-01)

AFFECTED PRODUCTS
The following versions of Emerson Ovation Controller OCR400, a process control device, are affected:
Emerson Ovation OCR400 Controller running Ovation Version 3.3.1 or earlier
These discontinued product versions include an embedded third-party FTP server, which is the vulnerable component. The vulnerable version of the FTP server was discontinued by that vendor several years ago.

QID Detection Logic (Authenticated):
QID checks for the Vulnerable version of using passive scanning

Successful exploitation of these vulnerabilities may allow privilege escalation or remote code execution, or it may halt the controller.For clarification, the referenced hardware is running a software version the vendor retired in July 2015. The identified vulnerabilities exist in a third-party embedded software version discontinued by that vendor.In addition, the vulnerable services are disabled by default in all product releases since 2007.

CVSS V3 rated as Critical - 8.8 severity.

CVSS V2 rated as High - 6.5 severity.

Solution

Customers are advised to refer to CERT MITIGATIONS section ICSA-19-148-01 for affected packages and patching details.

Vendor References

ICSA-19-148-01 - www.us-cert.gov/ics/advisories/ICSA-19-148-01

CVEs related to QID 590583

CVE-2019-10965 | CVE-2019-10967 |

Software Advisories

Advisory ID	Software	Component	Link
ICSA-19-148-01			www.us-cert.gov/ics/advisories/ICSA-19-148-01

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].